Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02057432 · ClinicalTrials.gov registry record · NA
Image-guided Breast Surgery in the Advanced Multimodality Image Guided Operating Suite (AMIGO)
A NA study of Stage II Breast Carcinoma and Stage I Breast Carcinoma, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 2
- Study locations
NCT02057432 is a NA study of Stage II Breast Carcinoma and Stage I Breast Carcinoma that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 15 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT02057432, a NA study of Stage II Breast Carcinoma and Stage I Breast Carcinoma, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 2
- Study locations
Study Summary
This research study is a pilot study designed to evaluate magnetic resonance imaging-guided therapy (MRT) as a possible treatment for breast cancer. In this pilot study, the investigators are studying if it is possible to use intra-operative MRI to guide surgery. The therapy takes place in the Advanced Multimodality Image Guided Operating (AMIGO) suite at Brigham and Women's Hospital. The purpose of this study is to investigate if it is possible to perform the breast conserving surgery with the help of intra-operative magnetic resonance imaging in the advanced multimodality image guided operating suite. It is hoped that intra operative MRI may improve the surgeon's ability to know the exact margins of tumor. Currently, approximately 40% of women need to come back to the operating room and have the margins of the cancer re-excised.
Conditions Studied
Interventions
- DEVICE intra-operative MRI
Study Locations (2)
Massachusetts
- Dana-Farber Cancer Institute - Boston
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2012-04 |
| Est. Completion | 2016-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02057432
The ClinicalTrials.gov registry entry for NCT02057432 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Stage II Breast Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which intra-operative MRI is the first listed.
NCT02057432 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02057432 about?
NCT02057432 is a clinical study titled "Image-guided Breast Surgery in the Advanced Multimodality Image Guided Operating Suite (AMIGO)". This research study is a pilot study designed to evaluate magnetic resonance imaging-guided therapy (MRT) as a possible treatment for breast cancer. In this pilot study, the investigators are studying if it is possible to use intra-operative MRI to guide surgery. The therapy takes place in the Advan...
What is the current status of trial NCT02057432?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2012-04. Estimated completion is 2016-08.
What conditions does trial NCT02057432 study?
This clinical trial studies the following conditions: Stage II Breast Carcinoma, Stage I Breast Carcinoma.
What interventions are being tested in trial NCT02057432?
The interventions under investigation include: intra-operative MRI (DEVICE).
Who is sponsoring clinical trial NCT02057432?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02057432 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage II Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.